A new approach to modulating the extracellular metabolites of biofilm cells to enhance the ability of antimicrobial agents
About
This technology utilizes a new approach to modulating the extracellular metabolites of biofilm cells to enhance the ability of antimicrobial agents and/or the immune system to control the growth and persistence of microorganisms in medical settings and aqueous systems. RB567
Key Benefits
(1) Biodegradable. (2) Non-toxic. (3) Approach capable of targeting resistant biofilm cells. (4) Mechanism of action and experimental data suggest very low likelihood of the emergence of resistance. (5) Can be used synergistically with other antimicrobials and dispersion-inducing compounds.
Applications
Targeting chronic biofilm infections. Disinfection of bacterial biofilms on surfaces.